Loading stock data…
NUS
$5.44+0.12 (+2.26%)
After Hours$5.54+0.10 (+1.84%)· Last close Jun 9
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nu Skin Enterprises, Inc. in the Consumer Defensive sector is trading at $5.44. The stock is currently near its 52-week low of $5.19, remaining 40.5% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$5.44
Potential Downside
0%
Whystock Fair Value$5.44
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiS...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
3.31%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.87%
Volume
Today's trading volume
448,483
Recent News
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with balance-sheet and value checks for upside.
Nu Skin Enterprises, Inc. (NYSE:NUS) Goes Ex-Dividend Soon
Nu Skin Enterprises, Inc. ( NYSE:NUS ) is about to trade ex-dividend in the next four days. Typically, the ex-dividend...
ELF Q4 Earnings Surpass Estimates, Net Sales Increase Y/Y
e.l.f. Beauty posts fiscal fourth quarter sales growth of 35.1% as Rhode boosts results, while margins face pressure from higher operating costs.
5 Value Stocks Trading at Attractive Price-to-Sales Ratios
Low price-to-sales stocks like SCVL, NUS, APLE, COP and FAF screen as undervalued, with the setup hinging on debt levels, strong cash flow and business momentum.
3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends
EL, NUS and COTY tap AI, wellness and innovation trends as beauty demand evolves across skincare, cosmetics and fragrance categories.